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Abstract
Objective: Post-stroke major depressive episode is very frequent, but underdiagnosed. Researchers have investigated major depressive 
episode symptomatology, which may increase its detection. This study was developed to identify the depressive symptoms that better 
differentiate post-stroke patients with major depressive episode from those without major depressive episode. Method: We screened 
260 consecutive ischemic stroke patients admitted to the neurology clinic of a university hospital. Seventy-three patients were eligible 
and prospectively evaluated. We assessed the diagnosis of major depressive episode using the Structured Clinical Interview for DSM-IV 
and the profile of depressive symptoms using the 31-item version of the Hamilton Depression Rating Scale. For data analysis we used 
cluster analyses and logistic regression equations. Results: Twenty-one (28.8%) patients had a major depressive episode. The odds ratio 
of being diagnosed with major depressive episode was 3.86; (95% CI, 1.23-12.04) for an increase of one unit in the cluster composed 
by the domains of fatigue/interest and retardation, and 2.39 (95% CI, 1.21-4.71) for an increase of one unit in the cluster composed 
by the domains of cognitive, accessory and anxiety symptoms. The domains of eating/weight and insomnia did not contribute for the 
major depressive episode diagnosis. Conclusion: The domains of retardation and interest/fatigue are the most relevant for the diagnosis 
of major depressive episode after stroke.
Descriptors: Stroke; Depression; Depressive disorder, major; Signs and symptoms; Clustering
Resumo
Objetivo: O episódio depressivo maior após acidente vascular cerebral é muito frequente, mas é subdiagnosticado. Pesquisas têm 
investigado a sintomatologia do episódio depressivo maior pós-acidente vascular cerebral, o que pode facilitar sua identificação. Este 
estudo foi desenvolvido para identificar os sintomas depressivos que melhor diferenciam pacientes com episódio depressivo maior 
daqueles sem episódio depressivo maior após o acidente vascular cerebral. Método: Foram triados consecutivamente 260 pacientes 
com acidente vascular cerebral admitidos à enfermaria de neurologia de um hospital universitário, dos quais 73 pacientes foram 
acompanhados. Para investigar o diagnóstico de episódio depressivo maior foi utilizada a Entrevista Clinica Estruturada para DSM-IV 
e para a sintomatologia depressiva a Escala de Avaliação para Depressão de Hamilton, versão 31 itens. Para a análise dos dados foi 
utilizada a análise de clusters e regressão logística. Resultados: Vinte e um (28,8%) pacientes tiveram episódio depressivo maior. O odds 
ratio para o diagnóstico de episódio depressivo maior foi 3,86; (95% IC, 1,23-12,04) para um aumento de uma unidade no cluster 
dos domínios interesse/fadiga e lentificação, e 2,39 (95% IC, 1,21-4,71) para um aumento de uma unidade no cluster de domínios 
de sintomas cognitivos, acessórios e ansiedade. Os domínios apetite/peso e insônia não contribuíram para o diagnóstico de episódio 
depressivo maior. Conclusão: Os domínios de lentificação e interesse/fadiga são os mais relevantes para o diagnóstico do episódio 
depressivo maior após acidente vascular cerebral.
Descritores: Acidente cerebral vascular; Depressão; Transtorno depressivo maior; Sinais e sintomas; Análise por conglomerados
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Introduction
Major depressive episode (MDE) is a common complication of 
stroke, with a reported prevalence ranging from 10 to 34%.1,2
Depression after stroke is associated with increased mortality, 
impairment in physical activities and language functioning, and 
reduced quality of life.3,4 Diagnosis and treatment of post-stroke 
depression (PSD) have been associated with improvement in 
functional recovery and reduction in cognitive impairment.5 Thus, 
early recognition and management of depression have been 
considered as critical for functional improvement after stroke.6,7
However, detection of depression after stroke is bellow 20-50%.8
Although several factors may contribute to such under-detection, 
the first step to improve the diagnosis of depression is to recognize 
the most specific symptoms. In particular, symptoms relevant 
for diagnosing primary depression may not be as relevant for 
diagnosing depression in special populations such as elders,9 and 
depression associated with medical conditions including stroke. 
For instance, somatic symptoms such as fatigue, psychomotor 
retardation, reduced concentration, insomnia, and reduced appetite 
may be directly related to the cerebrovascular event and are not 
as useful in diagnosing depression after stroke. Of note, somatic 
symptoms of depression have been reported to compromise the 
response to treatment and to be associated with refractoriness and 
chronicity.10
Some studies have investigated the profile of depressive 
symptomatology in stroke patients by verifying the frequencies 
of neuropsychiatric symptoms11 or studying psychological and 
autonomic symptoms and signs associated with depressive mood.12
Several studies have suggested that depression after stroke has 
distinct psychopathological characteristics compared to primary 
depression13,14 and to depression associated with other medical 
conditions.15 Gainotti et al.13 found that MDE after stroke had a 
predominance of anxiety, catastrophic reactions, hyperemotionalism 
and reactive diurnal mood variations, whereas primary major 
depression had a predominance of depressed mood, guilt feelings, 
suicidal thoughts and an increase in early morning unexplained 
insomnia. In addition, Beblo and Driessen14 found that patients 
with PSD suffered from more serious physical signs of depression 
(appetite loss, weight loss, lack of energy) and fewer cyclic (diurnal 
variation, difficulty falling asleep, multiple awakenings during sleep, 
early morning awakening) and ideational disturbances (ideas of 
suicide, self-deprecation, pessimism, mood-congruent delusions) 
than those with primary major depression. Consistent with Gainotti 
et al.,13 Fedoroff et al.15 also found that anxiety symptoms were 
more frequent in acute stroke patients with major depression than in 
patients with major depression who had had either acute myocardial 
infarctions or acute spinal cord injury. In contrast, Caeiro et al.
reported that apathy/loss of interest was the only symptom with 
increased frequency in depressed acute stroke patients compared 
with depressed acute coronary patients within the first 4 days 
after the medical event.16 Taken together these studies support the 
notion that specific symptoms characterize post stroke depression, 
but inconsistencies among these reports may warrant additional 
research on this topic. 
Given the psychopathological specificity of PSD, several studies 
have investigated the symptoms that best explain the PSD 
diagnosis. Coster et al.2 using the 17-item Hamilton Depression 
Rating Scale (HAM-D-17) found that depressed mood followed by 
reduced appetite, thoughts of suicide, psychomotor retardation, 
psychic anxiety, and fatigue significantly distinguished post-stroke 
patients with MDE from non-depressed patients. In their study 
most psychological symptoms had relatively low discriminative 
properties.  
However, some methodological aspects should be taken into 
account to ensure that the results are representative of a post-stroke 
depression (i.e., a depressive episode etiologically related to the 
stroke). For instance, the inclusion of patients with previous personal 
history of major depressive disorder (MDD) or previous stroke, 
patients with different types of stroke (intracerebral hemorrhage, 
intraventricular hemorrhage, subarachnoid hemorrhage and 
ischemic), and patients with stroke in the cerebellum and 
brainstem may have limited or diluted the conclusions about the 
psychopathology of PSD. The aim of this study was to identify the 
domains of depressive symptomatology that best explain diagnosis 
of MDE within 4 months after stroke. In an effort to accomplish 
this objective, we included only patients after their first-ever 
supratentorial ischemic stroke and without previous history of MDD. 
In addition, we used the 31-item version of the Hamilton Depression 
Rating Scale (HAM-D-31)17 to explore a more comprehensive 
psychopathological profile. 
Method
1. Patients
We screened 260 consecutive male and female inpatients, 18 
years or older, admitted to the neurological unit of the Clinical 
Hospital of the Universidade de São Paulo School of Medicine 
(HC-FMUSP) with diagnosis of ischemic stroke from August 2002 
to May 2007. The clinical diagnosis of stroke was performed by 
a neurologist according to the World Health Organization criteria18
and confirmed by magnetic resonance imaging (MRI). Patients 
were excluded from the study if they had history of stroke or other 
central nervous system diseases (amyotrophic lateral sclerosis, 
subarachnoid hemorrhage, Binswanger’s disease, brain tumors, and 
multiple sclerosis), no supratentorial stroke, Cushing’s syndrome, 
alcohol and drug dependence in the last 12 months, history of 
MDE, current MDE with onset before the stroke, bipolar disorder, 
psychotic disorder, and aphasia that would restrict the interview. 
It was not possible to obtain information about history of MDE 
before stroke in 23 patients (patients with aphasia = 15, low level 
of consciousness = 2, severe physical condition = 3, and other 
reasons = 3). Of the 237 patients with complete previous history 
data, 77 met the inclusion and exclusion criteria and 73 of them 
were enrolled in the prospective phase of the study (four patients 
that met the inclusion and exclusion criteria refused to participate 
in the study). The institutional review board of the HCFMUSP-SP 
approved the study protocol and informed written consent was 
obtained from all included subjects. 
2. Assessment
The 73 enrolled patients were evaluated at three different intervals 
after stroke. The first evaluation occurred between 6 and 23 days 
(mean ± SD; 12 ± 3.8), the second between 30 and 51 days (36 
± 6), and the third between 83 and 108 days (92.3 ± 54) after 
the stroke. A psychiatrist performed the diagnosis of MDE, using 
the Structured Clinical Interview for DSM-IV (SCID)19 according to 
the Diagnostic and Statistical Manual of Mental Disorder, 4th edition 
(DSM-IV)20 and assessed the severity of depressive symptoms using 
the HAM–D-3117 in all three intervals. 
3. Statistics
In this study with 73 post-stroke patients, 21 with MDE and 
52 without MDE, we investigated the domains of depressive 
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symptoms from the HAM-D-31 that best predicted diagnosis of MDE 
performed with the SCID. We used the seven domains of depressive 
symptoms of the HAM-D-31 described  by Jarmeson et al.:21 1) 
cognitive symptoms (worthlessness, hopelessness, helplessness, 
depressed mood, guilt feelings); 2) accessory symptoms (loss of 
insight, paranoid symptoms, obsessive and compulsive symptoms, 
hypochondriasis, depersonalization and derealization, diurnal 
variation, agitation); 3) retardation (retardation, psychic retardation, 
motoric retardation, loss of libido); 4) fatigue/interest (oversleeping, 
hypersomnia, napping, work and interest, anergia); 5) eating/
weight symptoms (increased appetite, decreased appetite, weight 
gain, weight loss); 6) insomnia (middle insomnia, late insomnia, 
early insomnia); 7) anxiety (anxiety-psychic, anxiety-somatic). The 
suicidal item of the HAM-D-31 (item 3) was analyzed separately. 
For patients who met MDE criteria the domains were rated at 
evaluation in which they had the highest score in the HAM-D-31 
(before starting antidepressant treatment). For patients who did not 
meet criteria for MDE in any of the three post-stroke evaluations we 
first calculated the means of each HAM-D-31 symptom and then 
established the domains based on these means. We excluded the 
symptom of depressed mood from the cluster analysis since it was 
present in all depressed patients. The suicidal item of the HAM-D-31 
was analyzed separately due to its relevance and because it was not 
included in Jamerson’s study.21 We performed a cluster analysis with 
the seven domains of the HAM-D-31 symptoms to select the best 
model to predict the diagnosis of depression in our sample. With 
this model we first investigated symptomatology divided into three 
domains. A logistic regression analysis was performed. The stepwise 
method for selected variables was used for the final model.
Statistical analyses were performed using the Special Package 
for Social Sciences, version 14. Analyses of sociodemographic 
data were performed to verify whether the two groups of patients 
with and without MDE were comparable. The chi-square test or 
Fisher’s exact test were used for categorical variables. Continuous 
variables presented normal distribution according to the Kolmogorov-
Smirnov test and the t-test was then used to compare the two 
groups. Depressed and non-depressed patients presented equality 
of variances for age but not for the HAM-D-31, consequently we 
used the t-test for the former analysis and Welch’s test for the latter. 
Significance levels were set at alpha = 0.05.
Results
Seventy-three ischemic stroke patients were followed-up for four 
months (mean ± SD age, 48.7 ± 14.6; range 19 to 79 years; 
57.5% male). The incidence of MDE was 28.8% (21 patients). 
There were no statistically significant differences between patients 
with and without MDE in terms of gender, marital status, occupation, 
educational level, and mean age (Table 1). The average HAM-D-31 
score was 23.1 ± 5.2 in the group of patients with MDE and 5.7 
± 3.6 in non-depressed patients (p < 0.001). 
The best model of the cluster analysis resulted in the inclusion of 
three domains of symptoms: domain 1, composed of the domains 
of cognitive symptoms, accessory symptoms and anxiety; domain 2, 
composed of the domains of retardation and fatigue/interest; domain 
3, composed of the domains of eating/weight and insomnia.
Logistic regression analysis was performed using the MDE as the 
dependent variable and symptoms domains, gender and age as 
independent variables. The symptom domain including eating/weight 
and insomnia (domain 3), gender and age did not show significant 
association with diagnosis of MDE and was withdrawn from the 
final model. Retardation and fatigue/interest domains (domain 
2), and cognitive symptoms, domain of accessory symptoms and 
anxiety domains (domain 1) were each independently associated 
with the presence of MDE within 4 months after stroke in regression 
analyses. Table 2 shows that patients with an increase in one unit 
in the symptoms domains of domain 2 (retardation, fatigue/interest 
domains) were associated with an almost four times greater risk 
of being diagnosed with MDE within 4 months after the stroke 
(odds ratio [OR], 3.86; 95% CI, 1.23-12.04). An increase of 
one unit in the score of domain 1 (cognitive symptoms, accessory 
symptoms and anxiety domains) had more than a two-fold risk of 
being diagnosed with MDE (OR, 2.39; 95% CI, 1.21-4.71). Eight 
patients (11%) scored in the suicidal ideation item of HAM-D-31, 
six (28.6%) of the 21 patients with MDE and two (3.9%) of the 52 
patients without MDE (p = 0.006). In the logistic regression analysis 
with MDE within 4 months after stroke as the dependent variable, an 
increase in one unit in the suicidal ideation symptom was associated 
with a seven-fold risk of being diagnosed with MDE (OR, 7.85; 95% 
CI, 1.29- 47.96) independently of age and gender.
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Discussion
We investigated the psychopathology of incident MDE in 73 
first ever supratentorial ischemic stroke patients. The cohort was 
prospectively followed-up for 4 months. The cluster analysis 
revealed that the retardation and fatigue/interest domains were 
the best in explaining the diagnosis of MDE. These domains were 
composed of HAM-D-31 items: retardation; psychic retardation, 
motor retardation, loss of libido, oversleeping, hypersomnia, 
napping, work and interest, and anergia. These findings reinforce the 
relevance of retardation for the diagnosis of depression after stroke 
suggested by previous studies.2,22 Lipsey et al. compared groups of 
patients with MDE after stroke and patients with functional major 
depression using the Present State Examination (PSE) syndrome 
profile, and also reported that the cluster of slowness (slowness and 
underactivity, slow speech, muteness, and restriction of quantity of 
speech) was more frequent in the group of patients with MDE after 
stroke.22 Coster et al. used the 17-item version of the HAM-D and 
found that psychomotor retardation and fatigue were among the 
symptoms with the strongest sensitivity for the diagnosis of MDE 
after stroke.2 It is important to stress that, in contrast to Coster et 
al., in our sample, decreased interest and energy were also good 
discriminators between depressed and non-depressed patients.2 To 
our knowledge this is the first report of the relevance of decreased 
interest in diagnosing PSD patients, although this symptom has 
been previously highlighted as a good discriminator to diagnosing 
depression in medically ill subjects in a general hospital.23
The domains of cognitive, anxiety, and accessory symptoms 
(domain 1) also explained the diagnoses of MDE after stroke 
although the odds ratio was lower compared to domain 2. The 
items of HAM-D-31 considered in domain 1 were worthlessness, 
hopelessness, helplessness, guilt feelings, loss of insight, paranoid 
symptoms, obsessive and compulsive symptoms, hypochondriasis, 
depersonalization and derealization, diurnal variation, agitation, 
anxiety psychic and anxiety somatic. Finally, the domains of 
insomnia and eating/weight did not explain the diagnosis of MDE 
after stroke. The symptoms comprised in these domains were 
increased or decreased appetite; weight gain or weight loss; middle 
insomnia; delayed insomnia and initial insomnia. This finding is 
in accordance with data reported by Coster et al.2 showing that 
early and middle insomnia, early morning awakening, and loss of 
weight had minor discriminative properties and most psychological 
symptoms, such as ‘hypochondriasis’, ‘lack of insight’ and ‘feelings 
of guilt’ had even lower discriminative power for the diagnosis 
of MDE after stroke. Corroborating these findings, Beblo and 
Driessen14 reported that patients with PSD suffered from fewer 
cyclic disturbances (diurnal variation, difficulty in falling asleep, 
multiple awakenings during sleep, early morning awakening) than 
those with primary depression. 
Depressed mood (not included in the cluster analysis) was 
present in all patients with MDE, suggesting that patients with loss 
of interest or pleasure as the only core symptom (“A” criterion) of 
MDE, or depressed patients denying the depressed mood, are not 
common after stroke. On this matter, Fedoroff et al.12 investigated the 
existence of post-stroke patients unable or unwilling to acknowledge 
their depressed mood. They reported that 46 of 205 patients met 
all the criteria for diagnosis of MDE according to DSM-III and only 
10 of 205 failed to meet the criteria only because they did not have 
depressed mood. These patients without depressed mood had a 
mean of one autonomic symptom, compared with a mean of almost 
four autonomic symptoms in the depressed group. The authors 
concluded that if there is “masked” depression (i.e. depression 
without depressed mood) after stroke, it occurs in a minority of 
patients. According to Paradiso et al.24  only 2% to 3% of post-stroke 
patients with depressive symptoms do not have depressed mood 
(i.e. “masked” depression). 
Suicidal ideation, as assessed by the HAM-D-31, was present 
in eight (11%) patients in this 4-month follow-up after stroke, a 
rate similar to those previously reported.  Kishi et al.25 found that 
6.6% of their patients had suicidal plans during the acute period 
after stroke in an in-hospital psychiatric evaluation. Pohjasvaara et 
al.,26 in a prospective study, found that suicidal ideas were present 
in 9.8% of their patients at 3 months, and in 14% at 15 months of 
follow-up after stroke. In our sample, suicidal ideation was present in 
six (28.6%) of the 21 patients with MDE, and a one-point increase 
in the item suicidal ideation was associated with an OR of 7.8 of 
being diagnosed with MDE. The rate of suicidal ideation in MDE 
patients in our sample is relatively higher than in previous reports, 
where it ranged between 14%2 and 18%.12
One strength of our results is that our sample was composed 
of patients without previous history of MDD at their first-ever, 
ischemic, supratentorial stroke. Secondly, we prospectively followed 
a cohort of stroke survivors, while others performed a cross-sectional 
evaluation12,13,27 or used a case-control design.14,15,22 Among 
those who developed a prospective study, the use of a two-step 
procedure to diagnose depression including a psychiatric evaluation 
only for those with suspicion of depression2 or including patients 
with previous stroke and previous history of depression limits the 
specificity of the conclusions.28
Another relevant point of our investigation is the use of the 
HAM-D-31, a more comprehensive scale, to evaluate depressive 
symptomatology. The advantage of the HAM-D-31 is that it includes 
some symptoms of the DSM-IV criteria for MDE not contemplated 
in other scales, such as the reverse vegetative symptoms (items 22 
to 28) including hypersomnia, oversleeping, napping, increased 
appetite, weight gain, psychic and motor retardation, and also 
cognitive symptoms (items 29 to 31) including  helplessness, 
hopelessness and worthlessness. 
The prospective nature of our study and the exclusion of patients 
with previous history of MDE allowed us to obtain data regarding 
incidence (and not prevalence) of MDE within the first 4 months 
after stroke. The four-month incidence of MDE of 28.8% found 
in our sample is similar to the 27% found between the second 
and fourth months after stroke13 and the 25% found between 3 
weeks and 3 months after stroke27 in studies that also excluded 
patients with previous history of depression, though both studies 
have performed cross-sectional evaluations. The prospective design 
of our study provides data about MDE incidence along various 
intervals after the stroke. For example, the incidence was 8.2% 
in the first month, 14.9% in the second month and 22.9% in the 
third month. An earlier prospective study developed by Robinson 
et al. found a 15% prevalence of MDE at 2 weeks and 22% at 
3 months after stroke in a sample of 40 patients.1 However, the 
authors included ischemic and hemorrhagic strokes, patients 
with stroke involving the brainstem and cerebellum, and patients 
with previous personal history of depression. Another prospective 
study, developed by Kauhanem et al.29 reported a 9% incidence of 
MDE at 3 months and 16% at 12 months after the first ischemic 
stroke. Although they excluded patients with previous history of 
depression, they also included patients with stroke in the brainstem 
and cerebellum. Aben et al., also in a prospective study, reported 
an incidence of joint major and minor depression of 21.6% at one 
month after stroke, 5.1% at three months, 6% at six months, 5.6% 
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at nine months and 7.1% at one year after stroke.30 The one-year 
cumulative incidence of depression was 38.7% with 23.3% being 
major depressive disorder and 15.4% minor depressive disorder. 
Although they excluded patients (4.1%) with current depressive 
episode at the time of the stroke, 21.8% of their patients had 
previous personal history of depression. In summary, our study is 
the first to use the prospective approach to investigate the incidence 
of MDE in patients with first ever supratentorial ischemic stroke 
without previous history of depression. 
A final contribution of our study regards the gender distribution 
of the incident post-stroke MDE. Although our sample was not 
specifically powered to evaluate gender distribution of depression, 
we did not find any association between gender and the 4-month 
cumulative incidence of MDE after stroke. On the other hand, a 
post-hoc analysis of baseline data including patients with previous 
history of depression revealed a trend of higher rate of previous 
history of depression in women (22.1%) compared to men (12.8%) 
(p = 0.057)  This previous gender distribution of MDE is in line with 
the literature consensus that the prevalence of MDD in women is 
two-fold that found for men in the general population.31 This absence 
of difference in gender distribution of MDE after stroke signalizes that 
post-stroke depression has distinct biological and/or psychological 
etiological factors. Although several studies have found similar 
results29,32-35 or even a positive association of male sex with MDE36
or with higher depressive symptomatology after stroke,37 some have 
reported an increased prevalence of MDE among females.16,28,30 The 
only study38 designed to verify the influence of sex on PSD reported 
a 12.3% prevalence of MDE for males and 23.6% for females at 
2 weeks after stroke. Methodological issues may have contributed 
to this discrepancy. Past personal history of depression and history 
of previous stroke have been reported to be risk factors for MDE 
after stroke.30,33-37 The inclusion of patients with such risk factors 
may have biased the gender ratio of depression after stroke. For 
example, including patients with previous history of depression will 
probably inflate the occurrence of MDE in females, because of the 
2:1 (female/male) ratio of depression in the general population, as 
mentioned above. Paradiso and Robinson’s finding38 may support 
this hypothesis since they found that the risk factor for depression 
in women was personal history of psychiatric disorder. On the 
contrary, men tend to have more stroke recurrence than women.39
Consequently, the inclusion of patients with recurrent stroke will 
probably inflate the occurrence of depression in males.
Several limitations of this study have to be considered. First, our 
sample is composed of patients in a teaching general hospital, 
restricting the generalization of results for patients from other 
settings. Second, we followed the patients for 4 months after stroke 
and incident depressive episodes after this period may have different 
psychopathological presentation. Third, in the infirmary evaluation 
we used the criteria of 1 week of depressive symptomatology instead 
of 2 weeks, as required by the DSM-IV. This may have overestimated 
the diagnosis of MDE in the first evaluation after stroke. Fourth, 
the use of stepwise selection procedures in our model may lead 
to results which only describe our current sample; independent 
studies will be needed to fully validate our results. Fifth, we did 
not investigate the influence of the lesion location and severity of 
neurologic impairment in the relationship between the domains of 
depressive symptoms and the diagnosis of the MDE. Although this 
was not the objective of our study, and others have also focused 
exclusively on the psychopathology,2 the inclusion of such data 
could further contribute to the understanding of the pathophysiology 
of the depressive symptoms and post-stroke MDE. Finally, cluster 
analysis does not define the contribution of any individual symptom 
for the diagnosis of MDE. However, this analysis allows physicians 
to identify the domain (cluster) of depressive symptoms with major 
weight when considering diagnosing MDE in stroke patients. 
Conclusion
Despite these limitations, our study suggests that the cluster 
retardation and the cluster fatigue/interest including several 
somatic symptoms (i.e., retardation, psychic retardation, motoric 
retardation, loss of libido, oversleeping, hypersomnia, napping, and 
anergia) were the best to differentiate patients with MDE after stroke 
from those non-depressed ones, independent of age and gender. 
Moreover, depressed mood proved to be an excellent marker of MDE 
and should be used as a target for clinicians screening for depression 
after stroke. These results support previous opinions for an inclusive 
approach to the diagnosis of depression in stroke patients2 and that 
the distinction between symptoms due to depression and those due 
to medical illness is not crucial for MDE diagnosis.12
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